Save your place

Sign in to WhoBought

Please try again later.

Unicycive Therapeutics, Inc. (UNCY) institutional ownership

Latest close $5.13 Jul 27, 2026
Market cap$53M 52-week range SectorHealthcare
Funds holding · Q1 2026
41
reported UNCY position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
28 buyers · 13 sellers

Unicycive Therapeutics, Inc. (UNCY) price and institutional activity

Dates

Q1 2026

$0 bought by 28 investors
Millennium Management LLCIntegral Health Asset Management, LLC +26 more
$0 sold by 13 investors
Cantor Fitzgerald, L. P.Squarepoint Ops LLC +11 more
Bought Sold Totals per quarter; hover a bar for the names.

Unicycive Therapeutics, Inc. (UNCY) institutional activity · 13

Investor Type Est. change Change Δ Own Date
Cantor Fitzgerald, L. P. · Reduced
Change −125K Date Q1 2026
Cantor Fitzgerald, L. P. Reduced· Q1 2026 −125K Q1 2026
Squarepoint Ops LLC · Exited
Change −55K Δ Own −100.0% Date Q1 2026
Squarepoint Ops LLC Exited· Q1 2026 −55K −100.0% Q1 2026
Omers Administration Corp · Reduced
Change −46K Date Q1 2026
Omers Administration Corp Reduced· Q1 2026 −46K Q1 2026
Citadel Advisors LLC Reduced· Q1 2026 −21K −8.3% Q1 2026
Xtx Topco Ltd · Reduced
Change −13K Date Q1 2026
Xtx Topco Ltd Reduced· Q1 2026 −13K Q1 2026
Quadrature Capital Ltd · Reduced
Change −11K Date Q1 2026
Quadrature Capital Ltd Reduced· Q1 2026 −11K Q1 2026
Acuta Capital Partners, LLC · Reduced
Change −2K Date Q1 2026
Acuta Capital Partners, LLC Reduced· Q1 2026 −2K Q1 2026
Tower Research Capital LLC (trc) · Exited
Change −2K Δ Own −100.0% Date Q1 2026
Tower Research Capital LLC (trc) Exited· Q1 2026 −2K −100.0% Q1 2026
Chicago Partners Investment Group LLC · Reduced
Change −635 Date Q1 2026
Chicago Partners Investment Group LLC Reduced· Q1 2026 −635 Q1 2026
UBS Group AG · Reduced
Change −461 Date Q1 2026
UBS Group AG Reduced· Q1 2026 −461 Q1 2026
BlackRock · Reduced
Change −452 Date Q1 2026
BlackRock Reduced· Q1 2026 −452 Q1 2026
Citigroup Inc · Reduced
Change −227 Date Q1 2026
Citigroup Inc Reduced· Q1 2026 −227 Q1 2026
Sbi Securities Co., Ltd. · Reduced
Change −1 Date Q1 2026
Sbi Securities Co., Ltd. Reduced· Q1 2026 −1 Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
13 of 13

Famous investor activity in Unicycive Therapeutics, Inc. (UNCY)

Unicycive Therapeutics, Inc. (UNCY) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Gupta Shalabh K. · Director Grant (A) 762K
Owned 762K Trade date May 14, 2026 Filed date May 21, 2026
Gupta Shalabh K. Director Grant (A) 762K 762K May 14, 2026 May 21, 2026
Kenkare-Mitra Sara · Director 2 operations 126K
Owned 126K Trade date May 14, 2026 Filed date May 21, 2026
Kenkare-Mitra Sara Director 2 operations 126K 126K May 14, 2026 May 21, 2026
Jermasek Douglas · Officer Grant (A) 170K
Owned 170K Trade date May 14, 2026 Filed date May 20, 2026
Jermasek Douglas Officer Grant (A) 170K 170K May 14, 2026 May 20, 2026
Gupta Pramod · Officer Grant (A) 170K
Owned 170K Trade date May 14, 2026 Filed date May 20, 2026
Gupta Pramod Officer Grant (A) 170K 170K May 14, 2026 May 20, 2026
Townsend John · CFO Grant (A) 170K
Owned 170K Trade date May 14, 2026 Filed date May 20, 2026
Townsend John CFO Grant (A) 170K 170K May 14, 2026 May 20, 2026
Laumas Sandeep · Director 2 operations 126K
Owned 126K Trade date May 14, 2026 Filed date May 18, 2026
Laumas Sandeep Director 2 operations 126K 126K May 14, 2026 May 18, 2026
Aggarwal Gaurav · Director Exercise or conversion (M/X/C) 653K
Owned 1.8M Trade date Aug 25, 2025 Filed date Aug 26, 2025
Aggarwal Gaurav Director Exercise or conversion (M/X/C) 653K 1.8M Aug 25, 2025 Aug 26, 2025
Aggarwal Gaurav · Director Shares transferred outside the market (D), often for tax or as a gift, not a market sale -$3.2M
Price $1,000.00 Qty -3K Owned 0 Trade date Aug 25, 2025 Filed date Aug 26, 2025
Aggarwal Gaurav Director Shares transferred outside the market (D), often for tax or as a gift, not a market sale $1,000.00 -3K -$3.2M 0 Aug 25, 2025 Aug 26, 2025
8 of 8

Unicycive Therapeutics, Inc. (UNCY) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Nantahala Capital Management, LLC 1.2M
% of shares outstanding 10.0% Filing date Aug 14, 2025
Nantahala Capital Management, LLC 1.2M 10.0% Aug 14, 2025
Vivo Opportunity Fund Holdings, L.P. 61.0M
% of shares outstanding 10.0% Filing date May 15, 2025
Vivo Opportunity Fund Holdings, L.P. 61.0M 10.0% May 15, 2025
Ra Capital Management, L.P. 2.8M
% of shares outstanding 9.9% Filing date May 15, 2026
Ra Capital Management, L.P. 2.8M 9.9% May 15, 2026
Octagon Capital Advisors LP 1.0M
% of shares outstanding 7.8% Filing date Aug 12, 2025
Octagon Capital Advisors LP 1.0M 7.8% Aug 12, 2025
Biotechnology Value Fund L P 777K
% of shares outstanding 5.7% Filing date Aug 14, 2025
Biotechnology Value Fund L P 777K 5.7% Aug 14, 2025
Walleye Capital LLC 5.0M
% of shares outstanding 4.8% Filing date Feb 6, 2025
Walleye Capital LLC 5.0M 4.8% Feb 6, 2025
Great Point Partners LLC 797K
% of shares outstanding 4.5% Filing date Nov 14, 2025
Great Point Partners LLC 797K 4.5% Nov 14, 2025
Integrated Core Strategies (us) LLC 206K
% of shares outstanding 0.8% Filing date Jul 8, 2026
Integrated Core Strategies (us) LLC 206K 0.8% Jul 8, 2026
8 of 8

Unicycive Therapeutics, Inc. (UNCY) ownership FAQ

Who owns UNCY?

41 reporting institutions disclosed UNCY position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.